Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/36367
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorGaleano Jaramillo, Elkin de Jesús-
dc.contributor.authorMartínez Martínez, Alejandro-
dc.contributor.authorRojas, Jhon J.-
dc.date.accessioned2023-08-25T16:22:10Z-
dc.date.available2023-08-25T16:22:10Z-
dc.date.issued2011-
dc.identifier.citationGaleano, E., Rojas, J. J., & Martínez, A. (2011). Pharmacological developments obtained from marine natural products and current pipeline perspective. Natural product communications, 6(2), 287–300.spa
dc.identifier.issn1934-578X-
dc.identifier.urihttps://hdl.handle.net/10495/36367-
dc.description.abstractABSTRACT: Marine organisms represent a new extensive source for bioactive molecules. They have the potential to provide new therapeutic alternatives to treat human diseases. In this paper, we describe and discuss a variety of isolated and semisynthetic molecules obtained from marine phase II, phase III and at the commercialization stage of new drug development. A description of the mechanism of action, dosage used and side effects are also reported. The positive results obtained from these studies have triggered the development of new studies to evaluate the prospects for utilization of marine organisms.spa
dc.format.extent14spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherSAGE Publicationsspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/2.5/co/*
dc.titlePharmacological Developments Obtained from Marine Natural Products and Current Pipeline Perspectivesspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupProductos Naturales Marinosspa
dc.identifier.doi10.1177/1934578X1100600233-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1555-9475-
oaire.citationtitleNatural product communicationsspa
oaire.citationstartpage287spa
oaire.citationendpage300spa
oaire.citationvolume6spa
oaire.citationissue2spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc/4.0/spa
dc.publisher.placeWesterville, Estados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAnimales-
dc.subject.decsAnimals-
dc.subject.decsProductos Biológicos - aislamiento y purificación-
dc.subject.decsBiological Products - isolation y purification-
dc.subject.decsProductos Biológicos - farmacología-
dc.subject.decsProductos Biológicos - pharmacology-
dc.subject.decsDescubrimiento de Drogas-
dc.subject.decsDrug Discovery-
dc.subject.decsOcéanos y Mares-
dc.subject.decsOceans and Seas-
dc.description.researchgroupidCOL0015043spa
dc.relation.ispartofjournalabbrevNat. Prod. Commun.spa
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
GaleanoElkin_2011_Pharmacological_Developments.pdfArtículo de investigación424.18 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons